Background Tuberculosis remains a global public health threat, and the development of
rapid and precise diagnostic tools is the key to enabling the early start of treatment …

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …

Introduction Despite huge efforts, tuberculosis (TB) is still a major public health threat
worldwide, it is estimated that a quarter of the global population is infected by …

Historically, research on the immunologic response to Mycobacterium tuberculosis (M. tb)
infection has focused on T cells and macrophages, as their role in granuloma formation has …

Diagnostic services for tuberculosis (TB) are not sufficiently accessible in low-resource
settings, where most cases occur, which was aggravated by the COVID-19 pandemic. Early …

Science has been taking profit from animal models since the first translational experiments
back in ancient Greece. From there, and across all history, several remarkable findings have …

Tuberculosis (TB) is a chronic granulomatous infectious disorder, caused by Mycobacterium
tuberculosis. Despite the recent advancements in antitubercular therapy (ATT), it remains a …

Despite advances in rapid molecular techniques for tuberculosis (TB) diagnostics, there is
an unmet need for a point-of-care, nonsputum-based test. Previously, through a T7 phage …

This review explores the evolving landscape of blood biomarkers in the diagnosis of
tuberculosis (TB), focusing on biomarkers derived both from the pathogen and the host …

Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide. Global research
efforts to improve TB control are hindered by insufficient understanding of the role that …